drugset / Trial / NCT03111381
Toradol to Reduce Ureteroscopic Symptoms Trial
RandomizedSingle-groupTriple-blindTreatment
Summary
Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 15 mg | Intravenous |
| Subject | Ketorolac | Other / unclassified | 30 mg | Intravenous |